What con­tro­ver­sy? Eli Lil­ly plots Alzheimer's BLA fil­ing lat­er this year as FDA taps more an­ti-amy­loid drugs as break­throughs

The FDA is keep­ing the good news com­ing for Alzheimer’s drug de­vel­op­ers. And Eli Lil­ly is tak­ing them up on it.

Amid con­tin­ued con­tro­ver­sy around …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.